{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-10-07",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "product_ndc": "0781-2270",
      "generic_name": "Butalbital, aspirin, and caffeine",
      "labeler_name": "Sandoz Inc",
      "dea_schedule": "CIII",
      "brand_name": "Butalbital, aspirin, and caffeine",
      "active_ingredients": [
        {
          "name": "BUTALBITAL",
          "strength": "50 mg/1"
        },
        {
          "name": "ASPIRIN",
          "strength": "325 mg/1"
        },
        {
          "name": "CAFFEINE",
          "strength": "40 mg/1"
        }
      ],
      "finished": true,
      "packaging": [
        {
          "package_ndc": "0781-2270-01",
          "description": "100 CAPSULE in 1 BOTTLE (0781-2270-01)",
          "marketing_start_date": "20240903",
          "sample": false
        }
      ],
      "listing_expiration_date": "20261231",
      "openfda": {
        "manufacturer_name": [
          "Sandoz Inc"
        ],
        "rxcui": [
          "238134"
        ],
        "spl_set_id": [
          "0e5e3842-fc6c-4a24-8e5c-522701f7c291"
        ],
        "is_original_packager": [
          true
        ],
        "nui": [
          "N0000175693",
          "M0002177",
          "N0000000160",
          "N0000008836",
          "M0001335",
          "N0000175722",
          "N0000175578",
          "N0000008832",
          "N0000175739",
          "N0000175729",
          "N0000175790",
          "M0023046"
        ],
        "pharm_class_epc": [
          "Barbiturate [EPC]",
          "Nonsteroidal Anti-inflammatory Drug [EPC]",
          "Platelet Aggregation Inhibitor [EPC]",
          "Central Nervous System Stimulant [EPC]",
          "Methylxanthine [EPC]"
        ],
        "pharm_class_cs": [
          "Barbiturates [CS]",
          "Anti-Inflammatory Agents, Non-Steroidal [CS]",
          "Xanthines [CS]"
        ],
        "pharm_class_moa": [
          "Cyclooxygenase Inhibitors [MoA]"
        ],
        "pharm_class_pe": [
          "Decreased Prostaglandin Production [PE]",
          "Decreased Platelet Aggregation [PE]",
          "Central Nervous System Stimulation [PE]"
        ],
        "unii": [
          "KHS0AZ4JVK",
          "R16CO5Y76E",
          "3G6A5W338E"
        ]
      },
      "marketing_category": "ANDA",
      "dosage_form": "CAPSULE",
      "spl_id": "e179c768-32ba-49b7-b59a-55b2cfa54619",
      "product_type": "HUMAN PRESCRIPTION DRUG",
      "route": [
        "ORAL"
      ],
      "marketing_start_date": "20240903",
      "product_id": "0781-2270_e179c768-32ba-49b7-b59a-55b2cfa54619",
      "application_number": "ANDA086996",
      "brand_name_base": "Butalbital, aspirin, and caffeine",
      "pharm_class": [
        "Anti-Inflammatory Agents",
        "Non-Steroidal [CS]",
        "Barbiturate [EPC]",
        "Barbiturates [CS]",
        "Central Nervous System Stimulant [EPC]",
        "Central Nervous System Stimulation [PE]",
        "Cyclooxygenase Inhibitors [MoA]",
        "Decreased Platelet Aggregation [PE]",
        "Decreased Prostaglandin Production [PE]",
        "Methylxanthine [EPC]",
        "Nonsteroidal Anti-inflammatory Drug [EPC]",
        "Platelet Aggregation Inhibitor [EPC]",
        "Xanthines [CS]"
      ]
    }
  ]
}